Ivan Doykov
Impact in
- Neurology top 5%
- Long-Term Effects of COVID-19
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 4
-
- Lysosomal Storage Disorders Research 6
- Co-authors
- Wendy Heywood (12 shared papers)Kevin A. Mills (12 shared papers)Jenny Hällqvist (6 shared papers)Louis Grandjean (2 shared papers)Kimberly Gilmour (2 shared papers)Philippa B. Mills (4 shared papers)Peter Theodore Clayton (3 shared papers)Albina Nowak (2 shared papers)
- Journals
- Nature Communications (3 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)npj Parkinson s Disease (2 papers)F1000Research (2 papers)Mechanisms of Ageing and Development (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Ivan Doykov
25 papers receiving 636 citations
Ivan Doykov's Hit Papers
Peers
Comparison fields: 5 of 76
- Neurology 270
- Infectious Diseases 134
- Neurology 48
- Critical Care and Intensive Care Medicine 27
- Physiology 110
Countries citing papers authored by Ivan Doykov
This map shows the geographic impact of Ivan Doykov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Doykov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Doykov more than expected).
Fields of papers citing papers by Ivan Doykov
This network shows the impact of papers produced by Ivan Doykov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Doykov. The network helps show where Ivan Doykov may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Doykov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 128 | |
| 2 | 2020 | 126 | |
| 3 | Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset Hit paper breakdown → | 2024 | 69 |
| 4 | 2016 | 56 | |
| 5 | 2022 | 51 | |
| 6 | 2019 | 29 | |
| 7 | 2022 | 24 | |
| 8 | 2022 | 22 | |
| 9 | 2015 | 21 | |
| 10 | 2019 | 17 | |
| 11 | 2020 | 15 | |
| 12 | 2023 | 14 | |
| 13 | 2024 | 14 | |
| 14 | 2019 | 11 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 7 | |
| 17 | 2024 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 6 |
About Ivan Doykov
Ivan Doykov is a scholar working on Neurology, Physiology, Infectious Diseases, Epidemiology and Cell Biology, having authored 26 papers that have together received 649 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (6 papers), COVID-19 Clinical Research Studies (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), SARS-CoV-2 detection and testing (3 papers), Cellular transport and secretion (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Neurology (270 citations), Infectious Diseases (134 citations), Neurology (48 citations), Critical Care and Intensive Care Medicine (27 citations) and Physiology (110 citations). Ivan Doykov has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Wendy Heywood, Kevin A. Mills, Jenny Hällqvist, Louis Grandjean, Kimberly Gilmour, Philippa B. Mills, Peter Theodore Clayton, Albina Nowak, Paul Gissen and David G. Warnock. Their work appears in journals such as Nature Communications, Clinical Chemistry and Laboratory Medicine (CCLM), npj Parkinson s Disease, F1000Research and Mechanisms of Ageing and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.